カプセル型吸入器の世界市場インサイト・予測(~2025年)

QYResearchが発行した調査報告書(QYR20FB06180)
◆英語タイトル:Global Capsule-based Inhalers Market Insights, Forecast to 2025
◆商品コード:QYR20FB06180
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月20日
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥661,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥992,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,323,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートでは、世界のカプセル型吸入器市場について調査・分析し、以下の構成でお届け致します。カプセル型吸入器の種類別には、ゼラチンカプセル、ヒプロメロースカプセルに、用途別には、喘息、COPD(慢性閉塞性肺疾患)に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別カプセル型吸入器売上データ
・地域別カプセル型吸入器市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別カプセル型吸入器市場規模:ゼラチンカプセル、ヒプロメロースカプセル
・用途別カプセル型吸入器市場規模:喘息、COPD(慢性閉塞性肺疾患)
・主要メーカーの企業情報:Hovione、Iconovo AB、Inbrija、Utibron Neohaler (Novartis AG)、Zibo Laixu Medical Equipment
・カプセル型吸入器の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...
【レポートの概要】

Capsule-based inhalers belong to the category of dry powder inhalers and work according to a simple two-step procedure. Capsules are punctured or opened by pressing the device buttons. Then, after inspiration, powder is absorbed into the lung pathway.The global Capsule-based Inhalers market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Capsule-based Inhalers market based on company, product type, end user and key regions.

This report studies the global market size of Capsule-based Inhalers in key regions like North America, Europe, China and Japan, focuses on the consumption of Capsule-based Inhalers in these regions.
This research report categorizes the global Capsule-based Inhalers market by top players/brands, region, type and end user. This report also studies the global Capsule-based Inhalers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Hovione
Iconovo AB
Inbrija
Utibron Neohaler (Novartis AG)
Zibo Laixu Medical Equipment

Capsule-based Inhalers market size by Type
Gelatin Capsules
Hypromellose Capsules

Capsule-based Inhalers market size by Applications
Asthma
COPD (Chronic Obstructive Pulmonary Disease)

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Capsule-based Inhalers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Capsule-based Inhalers market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Capsule-based Inhalers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Capsule-based Inhalers submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Capsule-based Inhalers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Capsule-based Inhalers market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Study Coverage
1.1 Capsule-based Inhalers Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Capsule-based Inhalers Market Size Growth Rate by Type
1.4.2 Gelatin Capsules
1.4.3 Hypromellose Capsules
1.5 Market by Application
1.5.1 Global Capsule-based Inhalers Market Size Growth Rate by Application
1.5.2 Asthma
1.5.3 COPD (Chronic Obstructive Pulmonary Disease)
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Capsule-based Inhalers Market Size
2.1.1 Global Capsule-based Inhalers Revenue 2014-2025
2.1.2 Global Capsule-based Inhalers Sales 2014-2025
2.2 Capsule-based Inhalers Growth Rate by Regions
2.2.1 Global Capsule-based Inhalers Sales by Regions
2.2.2 Global Capsule-based Inhalers Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Capsule-based Inhalers Sales by Manufacturers
3.1.1 Capsule-based Inhalers Sales by Manufacturers
3.1.2 Capsule-based Inhalers Sales Market Share by Manufacturers
3.2 Capsule-based Inhalers Revenue by Manufacturers
3.2.1 Capsule-based Inhalers Revenue by Manufacturers (2014-2019)
3.2.2 Capsule-based Inhalers Revenue Share by Manufacturers (2014-2019)
3.3 Capsule-based Inhalers Price by Manufacturers
3.4 Capsule-based Inhalers Manufacturing Base Distribution, Product Types
3.4.1 Capsule-based Inhalers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Capsule-based Inhalers Product Type
3.4.3 Date of International Manufacturers Enter into Capsule-based Inhalers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Capsule-based Inhalers Sales by Type
4.2 Global Capsule-based Inhalers Revenue by Type
4.3 Capsule-based Inhalers Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Capsule-based Inhalers Breakdown Data by Application

6 North America
6.1 North America Capsule-based Inhalers by Country
6.1.1 North America Capsule-based Inhalers Sales by Country
6.1.2 North America Capsule-based Inhalers Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Capsule-based Inhalers by Type
6.3 North America Capsule-based Inhalers by Application

7 Europe
7.1 Europe Capsule-based Inhalers by Country
7.1.1 Europe Capsule-based Inhalers Sales by Country
7.1.2 Europe Capsule-based Inhalers Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Capsule-based Inhalers by Type
7.3 Europe Capsule-based Inhalers by Application

8 Asia Pacific
8.1 Asia Pacific Capsule-based Inhalers by Region
8.1.1 Asia Pacific Capsule-based Inhalers Sales by Region
8.1.2 Asia Pacific Capsule-based Inhalers Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Capsule-based Inhalers by Type
8.3 Asia Pacific Capsule-based Inhalers by Application

9 Central & South America
9.1 Central & South America Capsule-based Inhalers by Country
9.1.1 Central & South America Capsule-based Inhalers Sales by Country
9.1.2 Central & South America Capsule-based Inhalers Revenue by Country
9.1.3 Brazil
9.2 Central & South America Capsule-based Inhalers by Type
9.3 Central & South America Capsule-based Inhalers by Application

10 Middle East and Africa
10.1 Middle East and Africa Capsule-based Inhalers by Country
10.1.1 Middle East and Africa Capsule-based Inhalers Sales by Country
10.1.2 Middle East and Africa Capsule-based Inhalers Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Capsule-based Inhalers by Type
10.3 Middle East and Africa Capsule-based Inhalers by Application

11 Company Profiles
11.1 Hovione
11.1.1 Hovione Company Details
11.1.2 Company Business Overview
11.1.3 Hovione Capsule-based Inhalers Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Hovione Capsule-based Inhalers Products Offered
11.1.5 Hovione Recent Development
11.2 Iconovo AB
11.2.1 Iconovo AB Company Details
11.2.2 Company Business Overview
11.2.3 Iconovo AB Capsule-based Inhalers Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Iconovo AB Capsule-based Inhalers Products Offered
11.2.5 Iconovo AB Recent Development
11.3 Inbrija
11.3.1 Inbrija Company Details
11.3.2 Company Business Overview
11.3.3 Inbrija Capsule-based Inhalers Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Inbrija Capsule-based Inhalers Products Offered
11.3.5 Inbrija Recent Development
11.4 Utibron Neohaler (Novartis AG)
11.4.1 Utibron Neohaler (Novartis AG) Company Details
11.4.2 Company Business Overview
11.4.3 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Utibron Neohaler (Novartis AG) Capsule-based Inhalers Products Offered
11.4.5 Utibron Neohaler (Novartis AG) Recent Development
11.5 Zibo Laixu Medical Equipment
11.5.1 Zibo Laixu Medical Equipment Company Details
11.5.2 Company Business Overview
11.5.3 Zibo Laixu Medical Equipment Capsule-based Inhalers Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Zibo Laixu Medical Equipment Capsule-based Inhalers Products Offered
11.5.5 Zibo Laixu Medical Equipment Recent Development

12 Future Forecast
12.1 Capsule-based Inhalers Market Forecast by Regions
12.1.1 Global Capsule-based Inhalers Sales Forecast by Regions 2019-2025
12.1.2 Global Capsule-based Inhalers Revenue Forecast by Regions 2019-2025
12.2 Capsule-based Inhalers Market Forecast by Type
12.2.1 Global Capsule-based Inhalers Sales Forecast by Type 2019-2025
12.2.2 Global Capsule-based Inhalers Revenue Forecast by Type 2019-2025
12.3 Capsule-based Inhalers Market Forecast by Application
12.4 North America Capsule-based Inhalers Forecast
12.5 Europe Capsule-based Inhalers Forecast
12.6 Asia Pacific Capsule-based Inhalers Forecast
12.7 Central & South America Capsule-based Inhalers Forecast
12.8 Middle East and Africa Capsule-based Inhalers Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Capsule-based Inhalers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Hovione、Iconovo AB、Inbrija、Utibron Neohaler (Novartis AG)、Zibo Laixu Medical Equipment

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ カプセル型吸入器の世界市場インサイト・予測(~2025年)(Global Capsule-based Inhalers Market Insights, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。